Hand eczema is not contagious, meaning that it does not pass from person to person. It can interfere with daily activities, and it can cause a person to feel self-conscious. Stress and exposure to ...

Chronic hand eczema is a type of skin disease that affects the skin on your hands and wrists. While there is no cure for chronic hand eczema, different types of medicines can be used to help manage ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Please provide your email address to receive an email when new articles are posted on . In two phase 3 trials, delgocitinib cream improved hand eczema in a greater proportion of patients vs. vehicle.

A first-in-class topical pan-Janus kinase (JAK) inhibitor significantly improved symptoms of moderate to severe chronic hand eczema in two randomized phase III trials. At week 16, more patients ...

Every time Rebecca publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

San Diego — Data from an open-label extension study of delgocitinib cream reflects the positive phase 3 safety and efficacy results released > 1 year ago from two separate trials in patients with ...

A regulatory decision is expected in the second half of 2025. The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for delgocitinib cream as a treatment for ...

Anzupgo (delgocitinib) is the first and only topical medication specifically approved for adults with moderate to severe chronic hand eczema. In large clinical trials, the cream significantly improved ...

Raj Chovatiya, MD, PhD, MSCI, describes how delgocitinib offers a long-term solution for chronic hand eczema, transforming treatment beyond traditional corticosteroids. Topical corticosteroids have ...